Dietary Therapy for LDL Cholesterol Reduction: Evidence-Based Patterns for Cardiovascular Risk Management
文献摘要
Dyslipidemia, including elevated total and low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and elevated lipoprotein(a), affects approximately 20% to 30% of the global population. In the United States, about 25% of adults have an LDL-C level of 130 mg/dL or higher. Dyslipidemias are major contributors to cardiovascular disease, the leading cause of mortality worldwide. Across the lifespan, nutrition influences lipid metabolism, systemic inflammation, insulin sensitivity, and vascular health, underscoring the importance of nutrition regardless of whether pharmacologic therapy is ultimately required. Contemporary guidance has shifted from focusing on dietary cholesterol alone to prioritizing overall dietary patterns, fat quality, fiber intake, and whole-food sources. A healthy diet, as described in the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, carries a Class I recommendation for reducing cardiovascular disease (CVD) events. Nutrition therapy is a foundational nonpharmacologic strategy for managing dyslipidemias and for reducing the risk of atherosclerotic cardiovascular disease (ASCVD) and broader cardiometabolic complications. The National Lipid Association emphasizes that the main targets of nutrition interventions are LDL-C and non–high-density lipoprotein-C, which serve as surrogates for circulating atherogenic apoB-containing lipoprotein particles. Accumulating evidence shows that saturated fat intake, the macronutrients and foods that replace it, and the degree of food processing have a greater impact on LDL-C levels and cardiovascular outcomes than dietary cholesterol alone. As a result, modern dietary recommendations prioritize replacing saturated fats from sources such as butter, full-fat dairy, fatty meats, and tropical oils with unsaturated fats from plant oils, nuts, seeds, and fish; eliminating industrially produced trans fats; and emphasizing fiber-rich, minimally processed foods, rather than targeting cholesterol intake as a primary goal. Dietary therapy is appropriate both as first-line management for individuals with mild to moderate LDL-C elevation and as an adjunct to lipid-lowering medications in higher-risk populations. Professional guidance from major organizations, including the American College of Cardiology (ACC), the American Heart Association (AHA), and the Dietary Guidelines for Americans, consistently supports dietary patterns that reduce ASCVD risk. These include the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH) diet, plant-based and vegetarian dietary patterns, and the dietary portfolio approach, all of which emphasize high-quality fats, high fiber intake, and minimally processed foods. Core recommendations include limiting saturated fat intake, replacing saturated fats with monounsaturated and polyunsaturated fats, and increasing consumption of fiber-rich foods, including vegetables, fruits, legumes, whole grains, nuts, and seeds. This topic focuses on dietary strategies for the prevention and management of dyslipidemia. Pharmacologic approaches to hypercholesterolemia are addressed elsewhere in this series. Please see StatPearls companion topics "Hypercholesterolemia," "Hypertriglyceridemia," and "Familial Hypertriglyceridemia" for further discussion on the pharmacologic management of specific dyslipidemias.